Proper Name: Measles, Mumps and Rubella Vaccine, Live
Manufacturer: GlaxoSmithKline Biologicals SA
- For active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.
- Package Insert - PRIORIX
- Demographic Subgroup Information – Measles, Mumps and Rubella Vaccine, Live (PRIORIX)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.
- June 3, 2022 Summary Basis for Regulatory Action - PRIORIX
- June 3, 2022 Approval Letter - PRIORIX
- Approval History, Letters, Reviews and Related Documents - PRIORIX